Efficacy of IntraCoronary Erythropoietin Delivery BEfore Reperfusion-Gauging Infarct Size in Patients with Acute ST-segment Elevation Myocardial Infarction (ICEBERG)

International Heart Journal
Won-Woo SeoDong-Ju Choi

Abstract

Previous clinical studies have shown inconsistent results regarding the effect of erythropoietin in ST-segment elevation myocardial infarction (STEMI). This study investigated whether directed intracoronary infusion of darbepoetin-α into ischemic myocardium before reperfusion would reduce infarct size or post-infarct remodeling in STEMI patients.Eighty STEMI patients received one of the following treatments simultaneously with the first balloon inflation: intracoronary darbepoetin-α 300 μg (n = 40) or saline (n = 40), administered via the over-the-wire balloon system. The primary endpoint was infarct size estimated by serial cardiac enzyme levels after procedure. The secondary endpoints were (1) infarct size and proportion of salvaged myocardium measured with cardiac magnetic resonance (CMR) at baseline; (2) post-infarct remodeling (PIR), defined as an increase in left ventricular end-diastolic volume more than 20% at 4 months compared to the baseline on CMR; and (3) composite cardiovascular endpoints assessed at 4 months.The peak CK-MB [median 270.0 (interquartile range 139.8-356.3) versus 231.5 (131.0-408.5) ng/mL, P = 0.55] and troponin-I [128.5 (63.5-227.8) versus 109.0 (43.8-220.0) ng/mL, P = 0.52) ] did not differ between...Continue Reading

References

Apr 1, 1992·Physiological Reviews·W Jelkmann
Aug 1, 1973·Journal of Molecular and Cellular Cardiology·D J HearseE B Chain
Jun 1, 1995·Journal of Molecular and Cellular Cardiology·J P CleutjensK T Weber
Jun 28, 2002·The Annals of Pharmacotherapy·Melanie S Joy
Feb 14, 2004·Cardiovascular Research·Jakob Vinten-Johansen
Jul 5, 2005·Journal of the American College of Cardiology·Peter van der MeerRegien G Schoemaker
May 24, 2006·Journal of Pharmacological Sciences·Daisuke NishiyaMinoru Yoshiyama
Sep 15, 2007·The New England Journal of Medicine·Derek M Yellon, Derek J Hausenloy
Mar 25, 2008·Trends in Pharmacological Sciences·Niels P RiksenDerek M Yellon
Nov 13, 2009·International Journal of Cardiology·Maurizio FerrarioLuigi Tavazzi
Aug 31, 2010·European Heart Journal·Adriaan A VoorsUNKNOWN HEBE III Investigators
May 12, 2011·JAMA : the Journal of the American Medical Association·Samer S NajjarUNKNOWN REVEAL Investigators
Mar 14, 2012·Nature Reviews. Cardiology·Gregory B Lim
Jun 21, 2013·Cardiovascular Drugs and Therapy·Marieke L FokkemaAdriaan A Voors
Oct 8, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Yanting WenQian Gao
Mar 29, 2014·World Journal of Cardiology·Alberto Dominguez-RodriguezRussel J Reiter
Feb 27, 2018·International Heart Journal·Yongwang WangHongyin Du

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.